Primer: Bukwang Pharmaceutical (003000 KS) - May 2026
Bukwang Pharmaceutical is a South Korean pharmaceutical company with a diversified portfolio of prescription drugs, over-the-counter (OTC)...
124 Views
Potential Inclusions and Exclusions of KOSPI200 Rebalance in June As Highlighted by Locals
This article discusses the potential inclusions and exclusions of KOSPI200 rebalance in June 2022 (especially those that are highlighted by the...
519 Views
Korea Stock Market Monthly Recap #46 (March 2020)
The world will never be the same after COVID-19. We provided an extensive analysis of the on-going developments of COVID-19 in March. This novel...
465 Views
MediSetter Interview: Insight on Opportunities in Asia's Healthcare Industry
Introduction to MedisetterI had the pleasure of interviewing Anirban Lahiri of Medisetter to discuss some of the opportunities present in Asia's...
4.2k Views
OCI Holdings: Beneficiary of a Polysilicon Contract to SpaceX but NAV Analysis Suggests Fully Valued
OCI Holdings' share price rose by 24.9% to 235,000 won on 15 April, which was mainly due to news about the company's new solar polysilicon supply...
654 Views